Imaging of hyperfunctioning adrenal masses

References

• Pivonello R, De Martino MC, De Leo M, Lombardi G, Colao A. Cushing’s syndrome. Endocrinol. Metab. Clin. North Am.37(1), 135–149, ix (2008).
   PubMed Web of Science ®Google Scholar
• Young WF. Primary aldosteronism: renaissance of a syndrome. Clin. Endocrinol. (Oxf.)66(5), 607–618 (2007).
   PubMed Web of Science ®Google Scholar
• Karagiannis A, Mikhailidis DP, Athyros VG, Harsoulis F. Pheochromocytoma: an update on genetics and management. Endocr. Relat. Cancer14(4), 935–956 (2007).
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Sasagawa, Suzuki H, Izumi T, Kaneko H, Nakada T. The role of ultrasonography in the detection of adrenal masses: comparison with computed tomography and magnetic resonance imaging. Int. Urol. Nephrol.32(3), 303–306 (2001).
   Google Scholar
• Heinz-Peer G, Memarsadeghi M, Niederle B. Imaging of adrenal masses. Curr. Opin. Urol.17(1), 32–38 (2007).
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Wehrmann T, Hoffmann C, Herrmann G, Caspary WF, Seifert H. Detection of the adrenal glands by endoscopic or transabdominal ultrasound. Endoscopy29(9), 859–864 (1997).
   PubMed Web of Science ®Google Scholar
• Trojan J, Schwarz W, Sarrazin C, Thalhammer A, Vogl TJ, Dietrich CF. Role of ultrasonography in the detection of small adrenal masses. Ultraschall. Med.23(2), 96–100 (2002).
   PubMed Web of Science ®Google Scholar
• Little AF. Adrenal gland and renal sonography. World J. Surg.24(2), 171–182 (2000).
   PubMed Web of Science ®Google Scholar
• Lockhart ME, Smith JK, Kenney PJ. Imaging of adrenal masses. Eur. J. Radiol.41(2), 95–112 (2002).
   PubMed Web of Science ®Google Scholar
• Fassnacht M, Kenn W, Allolio B. Adrenal tumors: how to establish malignancy? J. Endocrinol. Invest.27(4), 387–399 (2004).
   PubMed Web of Science ®Google Scholar
• Young WF Jr. Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol. Metab. Clin. North Am.29(1), 159–185, x (2000).
   PubMed Web of Science ®Google Scholar
• Thompson GB, Young WF Jr. Adrenal incidentaloma. Curr. Opin. Oncol.15(1), 84–90 (2003).
   PubMed Web of Science ®Google Scholar
• Boland GW, Hahn PF, Peña C, Mueller PR. Adrenal masses: characterization with delayed contrast-enhanced CT. Radiology202(3), 693–696 (1997).
   PubMed Web of Science ®Google Scholar
• Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR. Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am. J. Roentgenol.175(5), 1411–1415 (2000).
   PubMed Web of Science ®Google Scholar
• Dunnick NR, Korobkin M. Imaging of adrenal incidentalomas: current status. AJR Am. J. Roentgenol.179(3), 559–568 (2002).
   PubMed Web of Science ®Google Scholar
• Lingam RK, Sohaib SA, Vlahos I et al. CT of primary hyperaldosteronism (Conn’s syndrome): the value of measuring the adrenal gland. AJR Am. J. Roentgenol.181(3), 843–849 (2003).
   PubMed Web of Science ®Google Scholar
• Rockall AG, Babar SA, Sohaib SA et al. CT and MR imaging of the adrenal glands in ACTH-independent Cushing syndrome. Radiographics24(2), 435–452 (2004).
   PubMed Web of Science ®Google Scholar
• Sohaib SA, Rockall AG, Reznek RH. Imaging functional adrenal disorders. Best Pract. Res. Clin. Endocrinol. Metab.19(2), 293–310 (2005).
   PubMed Web of Science ®Google Scholar
• Ilias I, Sahdev A, Reznek RH, Grossman AB, Pacak K. The optimal imaging of adrenal tumours: a comparison of different methods. Endocr. Relat. Cancer.14(3), 587–599 (2007).
   PubMed Web of Science ®Google Scholar
• Gross MD, Avram A, Fig LM, Rubello D. Contemporary adrenal scintigraphy. Eur. J. Nucl. Med. Mol. Imaging34(4), 547–557 (2007).
   PubMed Web of Science ®Google Scholar
• Mayo-Smith WW, Boland GW, Noto RB, Lee MJ. State-of-the-art adrenal imaging. Radiographics21(4), 995–1012 (2001).
   PubMed Web of Science ®Google Scholar
• Barzon L, Boscaro M. Diagnosis and management of adrenal incidentalomas. J. Urol.163(2), 398–407 (2000).
   PubMed Web of Science ®Google Scholar
• Imperiale A, Olianti C, Mannelli M, La Cava G, Pupi A. Tomographic evaluation of 131I 6β-iodomethyl-norcholesterol standardised uptake trend in clinically silent monolateral and bilateral adrenocortical incidentalomas. Q. J. Nucl. Med. Mol. Imaging49(3), 287–296 (2005).
   PubMed Web of Science ®Google Scholar
• Rubello D, Bui C, Casara D, Gross MD, Fig LM, Shapiro B. Functional scintigraphy of the adrenal gland. Eur. J. Endocrinol.147(1), 13–28 (2002).
   PubMed Web of Science ®Google Scholar
• Ilias I, Pacak K. Diagnosis and management of tumors of the adrenal medulla. Horm. Metab. Res.37(12), 717–721 (2005).
   PubMed Web of Science ®Google Scholar
• Bravo EL, Tagle R. Pheochromocytoma: state-of-the-art and future prospects. Endocr. Rev.24(4), 539–553 (2003).
   PubMed Web of Science ®Google Scholar
• van der Harst E, de Herder WW, Bruining HA et al. [123I]metaiodobenzylguanidine and [111In]octreotide uptake in benign and malignant pheochromocytomas. J. Clin. Endocrinol. Metab.86(2), 685–693 (2001).
   PubMed Web of Science ®Google Scholar
• Ilias I, Pacak K. Anatomical and functional imaging of metastatic pheochromocytoma. Ann. NY Acad. Sci.1018, 495–504 (2004).
   PubMed Web of Science ®Google Scholar
• Ueberberg B, Tourne H, Redman A et al. Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland. Horm. Metab. Res.37(12), 722–728 (2005).
   PubMed Web of Science ®Google Scholar
• Becherer A, Vierhapper H, Pötzi C et al. FDG-PET in adrenocortical carcinoma. Cancer Biother. Radiopharm.16(4), 289–295 (2001).
   PubMed Web of Science ®Google Scholar
• Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J. Nucl. Med.42(12), 1795–1799 (2001).
   PubMed Web of Science ®Google Scholar
• Metser U, Miller E, Lerman H, Lievshitz G, Avital S, Even-Sapir E. 18F-FDG PET/CT in the evaluation of adrenal masses. J. Nucl. Med.47(1), 32–37 (2006).
   PubMed Web of Science ®Google Scholar
• Timmers HJ, Kozupa A, Chen CC et al. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J. Clin. Oncol.25(16), 2262–2269 (2007).
   PubMed Web of Science ®Google Scholar
• Hennings J, Lindhe O, Bergström M, Långström B, Sundin A, Hellman P. 11C metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings. J. Clin. Endocrinol. Metab.91(4), 1410–1414 (2006).
   PubMed Web of Science ®Google Scholar
• Eriksson B, Orlefors H, Oberg K, Sundin A, Bergström M, Långström B. Developments in PET for the detection of endocrine tumours. Best Pract. Res. Clin. Endocrinol. Metab.19(2), 311–324 (2005).
   PubMed Web of Science ®Google Scholar
• Mann GN, Link JM, Pham P et al.11C metahydroxyephedrine and 18F fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma. Ann. Surg. Oncol.13(2), 187–197 (2006).
   PubMed Web of Science ®Google Scholar
• Ilias I, Yu J, Carrasquillo JA et al. Superiority of 6-18F-fluorodopamine positron emission tomography versus 131I-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J. Clin. Endocrinol. Metab.88(9), 4083–4087 (2003).
   PubMed Web of Science ®Google Scholar
• Hoegerle S, Nitzsche E, Altehoefer C et al. Pheochromocytomas: detection with 18F DOPA whole body PET – initial results. Radiology222(2), 507–512 (2002).
   PubMed Web of Science ®Google Scholar
• Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery136(6), 1227–1235 (2004).
   PubMed Web of Science ®Google Scholar
• Tan YY, Ogilvie JB, Triponez F et al. Selective use of adrenal venous sampling in the lateralization of aldosterone-producing adenomas. World J. Surg.30(5), 879–887 (2006).
   PubMed Web of Science ®Google Scholar